$27.38
+0.0650 (+0.238%)
At Close: Jun 03, 2026
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
01:00pm, Thursday, 17'th Feb 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel In Late March
Amylyx Pharma
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
01:32pm, Sunday, 13'th Feb 2022 Benzinga
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate
Galapagos receives transparency notification from EcoR1 Capital
09:01pm, Thursday, 03'rd Feb 2022 GlobeNewswire Inc.
Mechelen, Belgium; 03 February 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a new transparency notification from EcoR1 Capital, LLC.
Galapagos ontvangt transparantieverklaring van EcoR1 Capital
09:01pm, Thursday, 03'rd Feb 2022 GlobeNewswire Inc.
Mechelen, België; 03 februari 2022, 22.01 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) heeft een kennisgeving van belangrijke deelneming ontvangen van EcoR1 Capital, LL
Galapagos provides further insights into the treatment of ulcerative colitis at the European Crohn’s and Colitis Organization (ECCO) annual congress
09:01pm, Wednesday, 02'nd Feb 2022 GlobeNewswire Inc.
Mechelen, Belgium; 2 February 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) will present data at the European Crohn’s and Colitis Organization (ECCO) annual congress taking place 16-19 Feb
Galapagos geeft meer inzicht in de behandeling van colitis ulcerosa op het jaarlijkse congres van de European Crohn's and Colitis Organization (ECCO)
09:01pm, Wednesday, 02'nd Feb 2022 GlobeNewswire Inc.
Mechelen, België; 2 februari 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) zal op het jaarlijkse congres van de European Crohn's and Colitis Organization (ECCO) dat plaatsvindt van 16-19 fe
Why Galapagos Trounced the Market Today
11:07pm, Thursday, 27'th Jan 2022 The Motley Fool
A high-profile healthcare industry executive has been tapped as the company's new CEO.
Why Galapagos Trounced the Market Today
06:07pm, Thursday, 27'th Jan 2022
A high-profile healthcare industry executive has been tapped as the company's new CEO.
Galapagos at a six-month high after naming former J&J science chief as CEO
03:56pm, Thursday, 27'th Jan 2022 Seeking Alpha
Galapagos <> ADRs have recorded the biggest intraday gain since March 2019 to reach a six-month high after announcing that Paul Stoffels, former chief scientific officer at Johnson
Mid-Morning Market Update: US Markets Open Higher As GDP Rises 6.9% In Fourth Quarter
03:15pm, Thursday, 27'th Jan 2022 Benzinga
US stocks opened on a strong note on Thursday after the country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the prior quarter and also above market estimates of 5.5%. Following the market opening, the Dow traded up 1.43% to 34,657.34 while the NASDAQ rose 1.27% to 13,714.18. The S&P also rose, gaining, 1.43% to 4,412.35. Also check out these big insider trades here Leading and Lagging Sectors Energy shares jumped 2.1% on Thursday. Meanwhile, top gainers in the sector included FLEX LNG Ltd. (NYSE: FLNG ), up 7% and Clean Energy Fuels Corp. (NASDAQ: CLNE ) up 8%. In trading on Thursday, consumer discretionary shares rose by just 0.6%. Top Headline McDonald''s Corporation (NYSE: MCD ) reported weaker-than-expected results for its fourth quarter. McDonald''s reported adjusted earnings of $2.23 per share, missing the consensus of $2.34 per share. Net sales came in at $6.01 billion, versus the consensus of $6.03 billion. Equities Trading UP The National Security Group, Inc. (NASDAQ: NSEC ) shares shot up 68% to $15.08 after VR Insurance announced acquisition of the company.
The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study
12:57pm, Thursday, 27'th Jan 2022 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours:
Stocks In Focus
Atara To Sell Manufacturing Plant to Fuji's CDMO Unit For $100M
Atara Biotherapeutics, Inc. (NASDAQ: A
Galapagos creates 1M subscription rights
10:09pm, Wednesday, 26'th Jan 2022 Seeking Alpha
Galapagos (GLPG) said its supervisory board created 1M subscription rights under a new plan for the benefit of a company personnel
Galapagos creëert nieuw inschrijvingsrechtenplan
09:40pm, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.
Mechelen, België; 26 januari 2022, 22.40 CET; gereglementeerde informatie – Galapagos NV (Euronext & NASDAQ: GLPG) kondigt vandaag aan dat haar raad van toezicht 1.000.000 inschrijvingsrechten he
Galapagos creates new subscription right plan
09:40pm, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.
Mechelen, Belgium; 26 January 2022, 22.40 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its supervisory board created 1,000,000 subscription rights under
Galapagos ropes in Paul Stoffels as CEO
09:09pm, Wednesday, 26'th Jan 2022 Seeking Alpha
Galapagos (GLPG) names Paul Stoffels as CEO, effective Apr. 1.Stoffels will be replacing Onno van de Stolpe, who is retiring and will remain for a transition period till Apr
Sign In
Buy GLPG